These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22688504)

  • 41. Clostridium difficile infection in the pediatric surgery population.
    Chen KT; Stephens DJ; Anderson E; Acton R; Saltzman D; Hess DJ
    J Pediatr Surg; 2012 Jul; 47(7):1385-9. PubMed ID: 22813801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clostridium difficile and inflammatory bowel disease.
    Issa M; Ananthakrishnan AN; Binion DG
    Inflamm Bowel Dis; 2008 Oct; 14(10):1432-42. PubMed ID: 18484669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.
    McFarland LV; Clarridge JE; Beneda HW; Raugi GJ
    Clin Infect Dis; 2007 Nov; 45(9):1141-51. PubMed ID: 17918075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Limited clinical utility of Clostridium difficile toxin testing in infants in a pediatric hospital.
    Tang P; Roscoe M; Richardson SE
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):91-4. PubMed ID: 15964495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile.
    Bishara J; Peled N; Pitlik S; Samra Z
    J Hosp Infect; 2008 Apr; 68(4):308-14. PubMed ID: 18353491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea.
    Raveh D; Rabinowitz B; Breuer GS; Rudensky B; Yinnon AM
    Int J Antimicrob Agents; 2006 Sep; 28(3):231-7. PubMed ID: 16908119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic trends in Clostridium difficile detection in Finnish microbiology laboratories.
    Könönen E; Rasinperä M; Virolainen A; Mentula S; Lyytikäinen O
    Anaerobe; 2009 Dec; 15(6):261-5. PubMed ID: 19591954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology and risk factors for Clostridium difficile infection in children.
    Sandora TJ; Fung M; Flaherty K; Helsing L; Scanlon P; Potter-Bynoe G; Gidengil CA; Lee GM
    Pediatr Infect Dis J; 2011 Jul; 30(7):580-4. PubMed ID: 21233782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease.
    Jess T; Simonsen J; Nielsen NM; Jørgensen KT; Bager P; Ethelberg S; Frisch M
    Gut; 2011 Mar; 60(3):318-24. PubMed ID: 21193449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
    Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E
    Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Clostridium difficile on inflammatory bowel disease.
    Ananthakrishnan AN; Binion DG
    Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):589-600. PubMed ID: 20932144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clostridium difficile infection in the hospitalized pediatric population: increasing trend in disease incidence.
    Deshpande A; Pant C; Anderson MP; Donskey CJ; Sferra TJ
    Pediatr Infect Dis J; 2013 Oct; 32(10):1138-40. PubMed ID: 23546535
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease.
    Debast SB; van Kregten E; Oskam KM; van den Berg T; Van den Berg RJ; Kuijper EJ
    Clin Microbiol Infect; 2008 Jun; 14(6):622-4. PubMed ID: 18393996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
    Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
    Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of the detection of Clostridium difficile toxins in stools and presence of the clostridia in tissues of children.
    Guarner J; Bhatnagar J; Shane AL; Jones T; DeLeon-Carnes MN; Schemankewitz E; Zaki SR
    Hum Pathol; 2010 Nov; 41(11):1586-92. PubMed ID: 20656321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clostridium difficile toxin assay in psoriatic patients.
    Kumar B; Vaishnavi C; Sandhu K; Kaur I
    Trop Gastroenterol; 2004; 25(4):164-7. PubMed ID: 15912974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clostridium difficile in Crohn's disease.
    Wright JM; Adams SP; Gribble MJ; Bowie WR
    Can J Surg; 1984 Sep; 27(5):435-7. PubMed ID: 6478320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clostridium difficile infection and inflammatory bowel disease: what gastroenterologists and surgeons should know.
    Cojocariu C; Trifan A; Stoica O; Chihaia CA; Stanciu C
    Chirurgia (Bucur); 2014; 109(5):579-83. PubMed ID: 25532244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clostridium difficile and inflammatory bowel disease.
    Ananthakrishnan AN; Issa M; Binion DG
    Gastroenterol Clin North Am; 2009 Dec; 38(4):711-28. PubMed ID: 19913210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.